Kaival Brands Innovations Group, Inc. (KAVL) Stock Price & Analysis
Kaival Brands Innovations Group, Inc. (KAVL) rose 0.00% to USD 0.02 as of September 8, 2026 at 06:57 UTC, according to Nexqual real-time market data.
KAVL last closed at USD 0.02; the session ranged USD 0.03–0.03 on volume of 1 shares. Market capitalization is —, with a 52-week range of USD 0.01–0.88 (OQB). Source: Nexqual, September 8, 2026 at 06:57 UTC.
Key Statistics (as of September 8, 2026 at 06:57 UTC)
| Price | USD 0.02 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.02 |
| Open | USD 0.02 |
| Day Range | USD 0.03 – 0.03 |
| 52-Week Range | USD 0.01 – 0.88 |
| Volume | 1 shares |
| Market Cap | — |
| Exchange | OQB |
Technical Analysis (KAVL)
Nexqual's technical model rates KAVL "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:57 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.39 (neutral) |
| vs SMA50 | Below (USD 0.03) |
| MACD | -0 (negative) |
From Kaival Brands Innovations Group, Inc.'s Latest SEC 10-K Filing (filed 2026-01-29)
Partnerships
- The par value per share of the Common Stock was not affected by the 2024 Reverse Stock Split.   Bidi Debt Exchange Agreement   On October 25, 2024 we entered the Debt Exchange Agreement with Bidi pursuant to which we satisfied an outstanding debt of $1,275,000 we owed to Bidi under the A&R Distribution Agreement by the issuance of 1,400,144 shares of our common stock to Bidi.   9    
- Our current primary source of revenue is through an international licensing agreement with Philip Morris Products S.A. ("PMPSA"), a wholly owned affiliate of Philip Morris International Inc. ("PMI").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SMFL | Smart for Life, Inc. | USD 0 | ▲ 0% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
| DBGI | Digital Brands Group, Inc. | USD 3.77 | ▼ 15.66% |
| AREB | American Rebel Holdings, Inc. | USD 0.15 | ▼ 4.43% |
| REVB | Revelation Biosciences, Inc. | USD 1.01 | ▲ 1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:57 UTC. This page is informational and not investment advice.